Stay updated on AV-101 for Levodopa Dyskinesia: PD Clinical Trial

Sign up to get notified when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a Phase 2 study of AV-101 for levodopa-induced dyskinesia in people with Parkinson’s disease, including its study design, participation criteria, and outcome measures.
    Difference
    41%
    Check dated 2026-11-11T19:23:13.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, indicating a site release update. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T20:04:50.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T21:46:48.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2 while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T22:02:51.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision marker was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T22:04:56.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the expected study content with a basic error screen. The 403 page indicates the study record is currently inaccessible on ClinicalTrials.gov.
    Difference
    17%
    Check dated 2026-09-23T21:47:23.000Z thumbnail image

Stay in the know with updates to AV-101 for Levodopa Dyskinesia: PD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.